Marksans Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 18 shareholders own 61.7% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
43.8%	Mark Saldanha	198,491,553	₹32.9b	0%	no data
10.9%	OrbiMed Advisors LLC	49,324,324	₹8.2b	0%	1.45%
2.79%	quant Money Managers Ltd.	12,641,259	₹2.1b	4.98%	0.34%
1.39%	Dimensional Fund Advisors LP	6,315,091	₹1.0b	-1.24%	no data
1.28%	UTI Asset Management Company Limited	5,788,805	₹959.8m	30.3%	0.04%
0.62%	State Street Global Advisors, Inc.	2,796,764	₹463.7m	1.29%	no data
0.41%	BlackRock, Inc.	1,872,618	₹310.5m	24.1%	no data
0.15%	Investor Education and Protection Fund (IEPF)	701,464	₹116.3m	7.78%	no data
0.076%	Eaton Vance Management	345,400	₹57.3m	0%	no data
0.073%	American Century Investment Management Inc	330,401	₹54.8m	0%	no data
0.068%	Motilal Oswal Asset Management Company Limited	308,421	₹51.1m	32.6%	0.01%
0.049%	Sandra Saldanha	220,180	₹36.5m	0%	no data
0.042%	AXA Investment Managers S.A.	190,850	₹31.6m	0%	no data
0.027%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	123,332	₹20.5m	0%	no data
0.025%	Acadian Asset Management LLC	114,000	₹18.9m	0%	no data
0.0025%	BNY Mellon Asset Management	11,386	₹1.9m	37.3%	no data
0.00066%	Arvind Singh	3,000	₹495.9k	0%	no data
0.0003%	Groww Asset Management Limited	1,368	₹225.4k	68.7%	0.01%